Management of anemia in patients who decline blood transfusion

American Journal of Hematology
Aryeh Shander, Lawrence Tim Goodnough

Abstract

Declining a treatment modality should not be considered the same as refusal of medical care as illustrated by the management of Jehovah's Witness patients who do not accept transfusions. Over the years, a comprehensive set of strategies have been developed to meet the specific needs of these patients and these strategies are collectively called "Bloodless Medicine and Surgery" (BMS). The focus in BMS is to optimize the patients' hematopoietic capacity to increase hemoglobin (Hgb) level, minimize blood loss, improve hemostasis, and provide supportive strategies to minimize oxygen consumption and maximize oxygen utilization. We present 3 case reports that illustrate some of the challenges faced and measures available to effectively treat these patients. Under BMS programs, patients with extremely low hemoglobin levels, not conducive to survival under ordinary conditions, have survived and recovered without receiving allogeneic transfusions. Additionally, the valuable experience gained from caring for these patients has paved the way to develop the concept of Patient Blood Management as a standard care to benefit all patients, and not only those for whom blood is not an option.

References

May 8, 1986·The New England Journal of Medicine·B R Smoller, M S Kruskall
Mar 27, 1997·The New England Journal of Medicine·L T GoodnoughG L Andriole
Aug 31, 2002·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Vladimir MartynMichael F Leahy
Apr 19, 2003·Transfusion·Lawrence T GoodnoughRichard Spence
Apr 18, 2006·Critical Care Medicine·Caveh MadjdpourRichard B Weiskopf
Oct 21, 2006·Current Opinion in Hematology·Aryeh Shander, Lawrence T Goodnough
Apr 10, 2009·British Journal of Hospital Medicine·Aryeh ShanderMazyar Javidroozi
Oct 8, 2009·Anesthesiology·Tenille E RagoonananGregory M T Hare
Jun 15, 2011·Journal of Thrombosis and Haemostasis : JTH·C McLintock, A H James
Nov 25, 2011·Current Opinion in Anaesthesiology·Aryeh Shander, Mazyar Javidroozi
Dec 22, 2011·British Journal of Anaesthesia·A ShanderG M T Hare
Jan 13, 2012·The Mount Sinai Journal of Medicine, New York·Aryeh ShanderGregg Lobel
Apr 11, 2012·Anesthesiology·Lawrence Tim Goodnough, Aryeh Shander
Jul 14, 2012·Journal of Medical Ethics·Gregory L Bock
Nov 2, 2012·Anesthesia and Analgesia·Philippe Van Der LindenRichard B Weiskopf
May 28, 2013·Lancet·Donat R Spahn, Lawrence T Goodnough
Feb 4, 2014·British Journal of Anaesthesia·N M de LangeH C Scheepers
Apr 2, 2015·Current Opinion in Anaesthesiology·Aryeh Shander, Mazyar Javidroozi
May 6, 2015·World Journal of Critical Care Medicine·Bruno Adler Maccagnan Pinheiro BesenMarcelo Park
Oct 8, 2015·Obstetrics and Gynecology·Richard HubbardMark H Yazer
Mar 31, 2016·Journal of Thrombosis and Haemostasis : JTH·P CollinsUNKNOWN Subcommittees on Women' s Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation
Aug 25, 2016·Anesthesia and Analgesia·Ruth ShaylorAlexander J Butwick
Sep 20, 2016·Anesthesia and Analgesia·Aryeh ShanderMarisa B Marques
Nov 16, 2016·Clinics in Chest Medicine·Daniel Gilstrap, John Davies
Nov 20, 2016·Transfusion·Richard B WeiskopfToby A Silverman
Dec 19, 2016·Transfusion·Malte KrömkerJens Meier
Jan 31, 2017·Anesthesiology Clinics·Emily J Baird
Jun 20, 2017·Best Practice & Research. Clinical Anaesthesiology·Rachel Collis, Emilia Guasch

❮ Previous
Next ❯

Citations

May 7, 2020·Current Opinion in Anaesthesiology·Christina ChaeBobbieJean Sweitzer
Feb 13, 2021·Current Opinion in Anaesthesiology·Megan RashidCatherine Cooper
Nov 6, 2020·BMJ Case Reports·Catarina Reis-de-CarvalhoNuno Clode

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.